2 Soaring Stocks I’d Buy Without Hesitation

Two soaring stocks with unstoppable upward momentum are the top picks for growth investors.

| More on:
Hand writing Time for Action concept with red marker on transparent wipe board.

Image source: Getty Images

Rosenberg Research, an economic consulting firm, believes the TSX will outperform its U.S. counterparts if the Bank of Canada cuts interest rates ahead of the U.S. Federal Reserve. It happened on June 5, 2024, and the American central bank has yet to move.

However, as of this writing, Canada’s primary stock exchange is only ahead of the Dow Jones Industrial Average at +6.13% versus +4.3%. The broader S&P 500 Index is up 16.1% year to date, while the tech-heavy Nasdaq Composite outperforms with +21.2%. Nonetheless, there are viable and lucrative options on the TSX.

Growth investors should consider taking positions in ADF Group (TSX:DRX) and Vitalhub (TSX:VHI). These small-cap stocks are soaring this year. Given their astronomical capital gains from a year ago, I’d buy them without hesitation. Both also carry “strong buy” ratings from market analysts.

Niche player

ADF, which is in the industrial sector, operates in the metal fabrication industry. The $474.4 million company specializes in connection engineering, fabrication and installation of metal frames and heavy steel components. Industrial stocks are relatively stable thus far in 2024 (+8.08%), but at $15.52 per share, current ADF investors enjoy a 124.48% year-to-date gain. The overall return in three years is 305.3%.

In addition to offering turnkey service to its engineering service, ADF produces 125,000 tons of steel annually and specializes in complex installations. The company provide services such as design & engineering, fabrication & coating, and construction to clients in Canada and the United States.

ADF’s net income in fiscal 2024 (12 months ending January 31, 2024) climbed 151.9% to $37.6 million compared to fiscal 2023. In the first quarter (Q1) fiscal 2025, net income jumped 184.2% year over year to $15.3 million. The top line increased 33.8% to $107.4 million versus Q1 fiscal 2024.

“We started the 2025 fiscal year strong. With revenues for the three-month period ended April 30, 2024, exceeding $100 million, we are building on the momentum of the recent quarters. This increase in revenues also allows us to improve our margins and thus record a significant increase in net income,” said Jean Paschini, board chairman and chief executive officer (CEO) of ADF Group.  

Market analysts’ 12-month average price target is $23, or a 48.2% potential upside.

Digital transformation

The healthcare sector’s year-to-date gain is 2.49%, but Vitalhub outperforms with +87.25%. Had you invested $6,500 on year-end 2023, your money would be $12,151,57 today. This $387.25 million company operates in the health information services industry.

Vitalhub began operations in 2010 and provides technology solutions for health and human service providers in Canada, the U.S., the United Kingdom, Australia, Western Asia, and internationally. Allied solutions include electronic healthcare records, case management, care coordination and optimization, healthcare records, patient flow, engagement, and operational visibility.

Its CEO, Dan Matlow, said VitalHub kicked off 2024 with outstanding momentum. In Q1 2024, revenue rose 21.4% to $15.3 million versus Q1 2023, while net income skyrocketed 713% year over year to $1.32 million. Matlow concluded, “As we move through 2024, VitalHub is well-positioned to continue our growth trajectory.”

Vitalhub plans to expand its reach in existing markets, explore new opportunities, and enhance its product portfolio. Matlow is confident that its strong financial position supports the ambitious growth plans and Vitalhub to lead the digital transformation in healthcare.

Unstoppable momentum

ADF Group and Vitalhub are winning investments in 2024. With impending rate cuts, both stocks should continue their upward momentum.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Vitalhub. The Motley Fool has a disclosure policy.

More on Investing

A worker overlooks an oil refinery plant.
Energy Stocks

The Ultimate Energy Stock to Buy With $500 Right Now

Do you want to invest in the ultimate energy stock but only have $500? Here's one stock that can set…

Read more »

Young woman sat at laptop by a window
Dividend Stocks

5% Dividend Yield: Why I Will Be Buying and Holding This TSX Stock for Decades!

Stability and a healthy return potential are among the hallmarks of the so-called “forever stocks.” But while many stocks promise…

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Stocks for Beginners

Maximize Your $7,000 TFSA Limit in 2024 

The 2024 TFSA limit is $7,000, the highest since the 2015 limit of $10,000. You could maximize this limit by…

Read more »

thinking
Stock Market

Is Brookfield Business Partners a Buy in 2024?

Down 20% from all-time highs, Brookfield Business Partners is a cheap TSX stock that should be on top of your…

Read more »

grow money, wealth build
Dividend Stocks

Here’s the Average RESP Balance and How to Boost it Big Time

The RESP can be an excellent tool for saving for a child's future. But is the average enough? And where…

Read more »

Two colleagues working on new global financial strategy plan using tablet and laptop.
Dividend Stocks

Best Stock to Buy Right Now: Manulife vs. CIBC?

These stock have enjoyed massive rallies in the past year. Are more gains on the way?

Read more »

investment research
Dividend Stocks

How to Use Your TFSA to Earn $12,000 Per Year in Tax-Free Income

The TFSA can act like a part-time job when invested properly, using your funds to turn your investments into the…

Read more »

edit Sale sign, value, discount
Dividend Stocks

1 Magnificent TSX Dividend Stock Down 60% to Buy and Hold Forever

Northwest Healthcare Properties is an overlooked TSX stock that's yielding more than 6% with solid fundamentals.

Read more »